Journal of Drug Discovery and Research

Affiliation: Hematology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Dr. Hamed Soleimani Samarkhazan is a dedicated hematology researcher currently pursuing his Ph.D. at Shahid Beheshti University of Medical Sciences in Tehran. He holds an M.Sc. in Hematology and Transfusion Medicine and a B.Sc. in Laboratory Sciences from the University of Tehran. With over a decade of experience in academic and clinical settings, his areas of expertise include leukemia, stem cell biology, transfusion medicine, and molecular hematology. Dr. Soleimani has authored more than 10 peer-reviewed articles in prominent journals such as Biomarker Research and Clinical and Experimental Medicine, focusing on AML therapy and immunotherapeutic innovations. In addition, he has written over eight books covering critical topics in hematology and transfusion science. He actively contributes to scientific publishing as a reviewer for journals including Drug Delivery Letters and Regenerative Engineering and Translational Medicine. His technical skills span flow cytometry, immunophenotyping, and scientific writing. Fluent in Persian, Azari, Turkish, and English, Dr. Soleimani is committed to advancing research in precision medicine and innovative treatments for hematological disorders.